Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. China is one of the prominent markets with a significant growth rate for conjugate vaccines.

All Expanded Program on Immunization (EPI) vaccines (including tuberculosis, polio, measles, and diphtheria-tetanus-pertussis (DTP), hepatitis A and B, meningococcal, Japanese encephalitis, rubella and mumps) in China are free and mandatory for school admissions. Immunization clinics in China also offer non-EPI vaccines to children but for a fee (and are not covered by insurance programs), including influenza, varicella, Haemophilus influenza type B (Hib), rotavirus, and pneumococcal vaccines, among others.

Market Segmentation:

By disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type B
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others

By end user, the market is segmented into:
o Paediatric
o Adult

Key growth factors:

China is projected to be a significant market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the conjugated vaccines market in China. According to the United Nations, China is ageing more rapidly than almost any country in recent history. This acts as a key driver for adult vaccines, owing to more demand by the geriatric population. Since the toll of pneumococcal disease in China is enormous, pneumococcal vaccination could improve childrens health and save lives and is therefore a prime selection for inclusion in the EPI schedule.

Threats and key players:

o The China conjugate vaccine market is expected to have significantly high growth. China has spent tremendous resources on the elimination of measles, but such elimination efforts should be combined with other immunization initiatives, such as educating caregivers about the benefits of other vaccines. The Chinese public is receiving more information about measles than about pneumonia or meningitis. Measles vaccine is free in Shanghai, but pneumococcal vaccine requires payment, which impacts the decision of the public significantly as they are reluctant to pay and get vaccinated.
o Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

Whats covered in the report?

1. Overview of the China conjugate vaccine market
2. Market drivers, and challenges in the China conjugate vaccine market
3. Market trends in the China conjugate vaccine market
4. Historical, current and forecasted market size data for China based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) by revenue and by volume
5. Historical, current and forecasted market size data for China based on end user (paediatric and adult conjugate vaccines) by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the China market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook